Catalyst Wire Dossier Catalyst Wire Dossier

Vicinium

etileucel? (Note: Vicinium is an investigational antibody-drug conjugate; if uncertain, use Vicinium as brand and leave generic_null) · Sesen Bio, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Vicinium, covering 2020-05-12 to 2023-07-24. Get the full timeline:

Most recent: Clinical Trial Update: Vicinium Treatment for Subjects With Non-muscle Invasive Bladder Cancer Previously Treated With BCG [Phase 3]

See pricing